ArticleJournal for immunotherapy of cancer2023

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.

Kathryn R Michels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.